IP Library Granted Patent US 9,561,280
Granted Patent B2
US 9,561,280 · App. 14/793,886 · Granted Feb 7, 2017

Aqueous liquid bromfenac composition having preservative efficacy

Inventors: Shuichi Nishihata (Hyogo, JP); Wakiko Asayama (Hyogo, JP); Suzuka Iemoto (Hyogo, JP)
Assignee: SENJU PHARMACEUTICAL CO., LTD.
A61K47/186A61K9/08A61K31/14A61K31/196A61K47/18A61K47/26A61K9/0043A61K9/0046A61K9/0048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,561,280
App. No.
14/793,886
Granted
Feb 7, 2017
Kind
B2
Abstract

An aqueous liquid bromfenac composition containing (a) bromfenac or a salt thereof and (b) benzalkonium chloride, characterized by that the composition has preservative efficacy and that the concentration of (b) benzalkonium chloride is higher than 0.0005% and lower than 0.005%.

Claims (6)

1. A method for enhancing the preservative efficacy of an aqueous solution, the method comprising adding bromfenac or a salt thereof to the aqueous solution,

wherein the amount of bromfenac or a salt thereof added to the aqueous solution is 0.05% to 0.15%,

wherein the aqueous solution is an aqueous base which contains (a) 0.001 to 0.002% of benzalkonium chloride and (b) 0.025% or higher and lower than 0.25% of a non-ionic surfactant,

and wherein the aqueous solution has preservative efficacy with said bromfenac or salt thereof but does not have sufficient preservative efficacy without said bromfenac or salt thereof.

2. The method of claim 1 , wherein the enhancement of the preservative efficacy is evidenced by reduction in viable cell count of Pseudomonas aeruginosa.

3. The method of claim 1 , wherein the non-ionic surfactant is polysorbate 80.

Assignments (1)
CHANGE OF ADDRESS Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
Priority Claims (3)
JP 2011-007898 · Jan 18, 2011 · national
JP 2011-199480 · Sep 13, 2011 · national
JP 2011-289640 · Dec 28, 2011 · national
Continuity (2)
Division 13978258
Related Publication 20150306222A1 · Oct 29, 2015